InspireMD, Inc.

NasdaqCM:NSPR Stock Report

Market Cap: US$70.2m

InspireMD Management

Management criteria checks 1/4

InspireMD's CEO is Marvin Slosman, appointed in Jan 2020, has a tenure of 4.92 years. total yearly compensation is $3.22M, comprised of 14.6% salary and 85.4% bonuses, including company stock and options. directly owns 0.025% of the company’s shares, worth $17.20K. The average tenure of the management team and the board of directors is 1.3 years and 8.3 years respectively.

Key information

Marvin Slosman

Chief executive officer

US$3.2m

Total compensation

CEO salary percentage14.6%
CEO tenure4.9yrs
CEO ownership0.02%
Management average tenure1.3yrs
Board average tenure8.3yrs

Recent management updates

Recent updates

Here's Why We're Not Too Worried About InspireMD's (NASDAQ:NSPR) Cash Burn Situation

Jan 11
Here's Why We're Not Too Worried About InspireMD's (NASDAQ:NSPR) Cash Burn Situation

We Think InspireMD (NASDAQ:NSPR) Needs To Drive Business Growth Carefully

Jan 27
We Think InspireMD (NASDAQ:NSPR) Needs To Drive Business Growth Carefully

We're Keeping An Eye On InspireMD's (NASDAQ:NSPR) Cash Burn Rate

Oct 05
We're Keeping An Eye On InspireMD's (NASDAQ:NSPR) Cash Burn Rate

InspireMD: Revolutionizing The Field Of Vascular Stenting

Sep 20

Trade Alert: Gary Roubin At InspireMD, Inc. (NYSEMKT:NSPR), Has Just Spent US$150k Buying 52% More Shares

Feb 11
Trade Alert: Gary Roubin At InspireMD, Inc. (NYSEMKT:NSPR), Has Just Spent US$150k Buying 52% More Shares

CEO Compensation Analysis

How has Marvin Slosman's remuneration changed compared to InspireMD's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$26m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$3mUS$470k

-US$20m

Sep 30 2023n/an/a

-US$19m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$697kUS$433k

-US$18m

Sep 30 2022n/an/a

-US$18m

Jun 30 2022n/an/a

-US$17m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$2mUS$410k

-US$15m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$13m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$1mUS$367k

-US$11m

Compensation vs Market: Marvin's total compensation ($USD3.22M) is above average for companies of similar size in the US market ($USD646.54K).

Compensation vs Earnings: Marvin's compensation has increased whilst the company is unprofitable.

CEO

Marvin Slosman (60 yo)

4.9yrs

Tenure

US$3,219,321

Compensation

Mr. Marvin L. Slosman has been President, Chief Executive Officer and Director of InspireMD, Inc. since January 1, 2020. Mr. Slosman served as Chief Operating Officer for MEDCURA Incorporated from May 2019...

Leadership Team

NamePositionTenureCompensationOwnership
Marvin Slosman
President4.9yrsUS$3.22m0.025%
$ 17.2k
Craig Shore
CFO, Chief Administrative Officer1.2yrsUS$1.80m9.2%
$ 6.5m
Shane Gleason
Chief Commercial Officer1.3yrsUS$1.15m2.08%
$ 1.5m
Andrea Tommasoli
Chief Operating Officer1.8yrsUS$359.27k1.94%
$ 1.4m
Amir Kohen
Senior Vice President of Finance & HR1.2yrsno datano data
Patrick Verta
Executive Vice President of Clinical & Medical Affairs1.2yrsno data0.71%
$ 501.3k
Pete Ligotti
Executive VP & GM of North Americaless than a yearno datano data
Sol Barer
Special Advisor to the Boardno dataUS$13.92kno data

1.3yrs

Average Tenure

61.5yo

Average Age

Experienced Management: NSPR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Marvin Slosman
President4.9yrsUS$3.22m0.025%
$ 17.2k
Michael Berman
Independent Director11.8yrsUS$380.25k1.59%
$ 1.1m
Elazer Edelman
Member of Advisory Boardno datano datano data
Thomas Kester
Independent Director8.3yrsUS$385.25k1.25%
$ 878.7k
Antonio Colombo
Member of Advisory Boardno datano datano data
Alexandre Abizaid
Member of Advisory Boardno datano datano data
Martin B. Leon
Member of Advisory Boardno datano datano data
Eberhart Grube
Member of Advisory Boardno datano datano data
Paul Stuka
Independent Chairman of the Board13.3yrsUS$574.93k1.19%
$ 838.1k
Kenneth Rosenfield
Chair of Scientific Advisory Board3.7yrsno datano data
Yaron Almagor
Member of Advisory Boardno datano datano data
Edo Kaluski
Member of Advisory Boardno datano datano data

8.3yrs

Average Tenure

67yo

Average Age

Experienced Board: NSPR's board of directors are considered experienced (8.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 02:18
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InspireMD, Inc. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raymond MyersBenchmark Company
Keay NakaeChardan Capital Markets, LLC
Vernon BernardinoH.C. Wainwright & Co.